Supernus Pharmaceuticals, Inc. (SUPN)
29.72
+0.52
(+1.78%)
USD |
NASDAQ |
Nov 13, 16:00
29.30
-0.42
(-1.41%)
After-Hours: 19:59
Supernus Pharmaceuticals Price to Book Value : 1.630 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 1.630 |
| November 12, 2026 | 1.601 |
| November 11, 2026 | 1.615 |
| November 10, 2026 | 1.576 |
| November 09, 2026 | 1.514 |
| November 06, 2026 | 1.434 |
| November 05, 2026 | 1.466 |
| November 04, 2026 | 1.547 |
| November 03, 2026 | 1.543 |
| November 02, 2026 | 1.989 |
| October 30, 2026 | 2.298 |
| October 29, 2026 | 2.294 |
| October 28, 2026 | 2.252 |
| October 27, 2026 | 2.246 |
| October 26, 2026 | 2.235 |
| October 23, 2026 | 2.232 |
| October 22, 2026 | 2.307 |
| October 21, 2026 | 2.260 |
| October 20, 2026 | 2.261 |
| October 19, 2026 | 2.184 |
| October 16, 2026 | 2.077 |
| October 15, 2026 | 2.170 |
| October 14, 2026 | 2.203 |
| October 13, 2026 | 2.303 |
| October 12, 2026 | 2.347 |
| Date | Value |
|---|---|
| October 09, 2026 | 2.340 |
| October 08, 2026 | 2.310 |
| October 07, 2026 | 2.360 |
| October 06, 2026 | 2.348 |
| October 05, 2026 | 2.344 |
| October 02, 2026 | 2.324 |
| October 01, 2026 | 2.313 |
| September 30, 2026 | 2.360 |
| September 29, 2026 | 2.48 |
| September 28, 2026 | 2.516 |
| September 25, 2026 | 2.406 |
| September 24, 2026 | 2.442 |
| September 23, 2026 | 2.447 |
| September 22, 2026 | 2.468 |
| September 21, 2026 | 2.413 |
| September 18, 2026 | 2.369 |
| September 17, 2026 | 2.421 |
| September 16, 2026 | 2.334 |
| September 15, 2026 | 2.328 |
| September 14, 2026 | 2.340 |
| September 11, 2026 | 2.349 |
| September 10, 2026 | 2.351 |
| September 09, 2026 | 2.373 |
| September 08, 2026 | 2.393 |
| September 04, 2026 | 2.455 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.568 |
| Prestige Consumer Healthcare, Inc. | 1.126 |
| Structure Therapeutics, Inc. | 1.168 |
| Corcept Therapeutics, Inc. | 9.568 |
| Veru, Inc. | 1.256 |
Price to Book Value Related Metrics
| PS Ratio | 1.997 |
| PEG Ratio | -0.3121 |
| Price to Free Cash Flow | 19.87 |
| Price | 29.72 |
| Earnings Yield | -2.57% |
| Market Cap | 1.731B |
| PEGY Ratio | -0.2559 |
| Operating PE Ratio | 129.35 |